Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from India

Journal of the American Academy of Dermatology

Volumn 69, Issue 2, 2013, Pages 262-266

  Jahan, Parveen ^a   Cheruvu, Rajeshwari ^a   Tippisetty, Surekha ^a   Komaravalli, Prasanna Latha ^a   Valluri, Vijayalakshmi ^b   Ishaq, Mohammed ^a  

^a OSMANIA UNIVERSITY   (India)

^b LEPRA Society   (India)

Author keywords

autoimmunity; FOXP3 single nucleotide polymorphism rs3761548; gender; Indian population; nondermatomal; vitiligo; X chromosome

Indexed keywords

GENOMIC DNA; TRANSCRIPTION FACTOR FOXP3;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOXP3 GENE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; VITILIGO; X CHROMOSOME;

AUTOIMMUNITY; BASE PAIR; BP; CI; CONFIDENCE INTERVAL; FORKHEAD BOX P3; FOXP3; FOXP3 SINGLE-NUCLEOTIDE POLYMORPHISM RS3761548; GENDER; INDIAN POPULATION; NONDERMATOMAL; ODDS RATIO; OR; REGULATORY T CELLS; SINGLE-NUCLEOTIDE POLYMORPHISM; SNP; TREGS; VITILIGO; X-CHROMOSOME;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CHILD; CONFIDENCE INTERVALS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; SEX FACTORS; VITILIGO; YOUNG ADULT;

EID: 84880331235     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.01.035     Document Type: Article

References (25)

1. A. Alikhan, L.M. Felsten, M. Daly, and V. Petronic-Rosic Vitiligo: a comprehensive overview, part I: introduction, epidemiology, quality of life, diagnosis, differential diagnosis, association, histopathology, etiology, and work up J Am Acad Dermatol 65 2011 473 491
2. M. Ben Ahmed, I. Zaraa, R. Rekik, A. Elbeldi-Ferchiou, N. Kourda, and N. Belhadj Hmida Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo Pigment Cell Melanoma Res 25 2012 99 109
3. N. Oiso, T. Suzuki, K. Fukai, I. Katayama, and A. Kawada Non segmental vitiligo and autoimmune mechanism Dermatol Res Pract 2011 2011 518090
4. S.A. Birlea, Y. Jin, D.C. Bennett, D.M. Herbstman, M.R. Wallace, and W.T. McCormack Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP J Invest Dermatol 131 2011 371 381
5. R.A. Spritz The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma Genome Med 2 2010 78
6. H.J.J. van der Vliet, and E.E. Nieuwenhuis IPEX as a result of mutations in FOXP3 Clin Dev Immunol 2007 2007 89017
7. L. Gao, K. Li, F. Li, H. Li, L. Liu, and L. Wang Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients J Dermatol Sci 57 2010 51 56
8. O. Park, I. Grishina, P.S. Leung, M.E. Gershwin, and T. Prindiville Analysis of the Foxp3/scurfin gene in Crohn's disease Ann N Y Acad Sci 1051 2005 218 228
9. S. Tippisetty, I. Mohammed, P.L. Komaravalli, and P. Jahan Angiotensin converting enzyme (ACE) gene polymorphism in vitiligo: protective and predisposing effects of genotypes in disease susceptibility and progression Eur J Dermatol 21 2011 173 177
10. T.R. Torgerson Regulatory T cells in human autoimmune diseases Springer Semin Immunopathol 28 2006 63 76
11. + T cells in normal skin and inflammatory dermatoses J Histochem Cytochem 55 2007 891 898
12. L.M. Williams, and A.Y. Rudensky Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 Nat Immunol 8 2007 277 284
13. Y.Y. Wan, and R.A. Flavell Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression Nature 445 2007 766 770
14. Y.C. Lin, J.H. Lee, A.S. Wu, C.Y. Tsai, H.H. Yu, and L.C. Wang Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case-control study Lupus 20 2011 137 143
15. N. Inoue, M. Watanabe, M. Morita, R. Tomizawa, T. Akamizu, and K. Tatsumi Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases Clin Exp Immunol 162 2010 402 406
16. L. Zhang, Y. Zhang, M. Desrosiers, C. Wang, Y. Zhao, and D. Han Genetic association study of Foxp3 gene polymorphism in allergic rhinitis in a Chinese population Hum Immunol 70 2009 930 934
17. Z. Shen, L. Chen, F. Hao, G. Wang, and Y. Liu Intron-1 rs3761548 is related to the defective transcription of Foxp3 in psoriasis through abrogating E47/c-Myb binding J Cell Mol Med 14 2010 226 241
18. Z. Wu, Z. You, C. Zhang, Z. Li, X. Su, and X. Zhang Association between functional polymorphisms of Foxp3 gene and the occurrence of unexplained recurrent spontaneous abortion in a Chinese Han population Clin Dev Immunol 2012 2012 896458
19. P. Jahan, R. Srinivasagari, D. Goudi, P.L. Komaravalli, and M. Ishaq Role of Foxp3 gene in maternal susceptibility to pre-eclampsia-a study from South India Scand J Immunol 77 2013 104 108
20. S.L. Klein Immune cells have sex and so should journal articles Endocrinology 153 2012 2544 2550
21. Li HX. Relationship between regulatory T cell and FoxP3 gene polymorphism and vitiligo 2010 China papers, China's outstanding master's theses part C. GT ID2144360245498320.
22. T. Surekha, M. Ishaq, K.P. Latha, P.H. Rao, and P. Jahan Do clinical variants of vitiligo involve X-linked gene(s) too? J Med Sci 8 2008 728 733
23. T. Surekha, M. Ishaq, and P. Jahan Parent-of-origin effect; a hint from vitiligo epidemiology J Dermatol 38 2011 947 949
24. J.C. Broen, I.L. Wolvers-Tettero, L. Geurts-van Bon, M.C. Vonk, M.J. Coenen, and R. Lafyatis Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis Ann Rheum Dis 69 2010 2213 2216
25. + regulatory T cells and Foxp3 expression on the pathogenesis of vitiligo Chin J Aesthetic Med 8 2009 819 822